ProPhase Labs Inc. held its Annual Meeting of Stockholders on July 18, 2025. During the meeting, stockholders voted on several proposals. The election of directors was approved, with Ted Karkus, Louis Gleckel, MD, Warren Hirsch, and Carolina Abenante, ESQ. being elected to the board. The appointment of Fruci & Associates II, PLLC as the company's independent auditors for the fiscal year ending December 31, 2025, was ratified. The frequency of future advisory votes on executive compensation was set to every three years. Following the meeting, Ms. Abenante was appointed to the Audit Committee, bringing the company into compliance with Nasdaq Listing Rules.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.